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The FDA-approved platinum compound, cisplatin, is commonly used as a 
chemotherapy drug to treat many forms of cancer.  However, this compound also has 
several associated side-effects, including ototoxicity.  This has made the development of 
novel platinum compounds that reduce cancer cell viability, while causing fewer and 
milder side-effects, an area of significant research interest.  In the present study, we 
examined the apoptotic effects that four monofunctional platinum compounds, 
pyriplatin, phenanthriplatin, Pt(diethylenetriamine)Cl, and Pt(N,N-
diethyldiethylenetriamine)Cl, had on zebrafish inner ear auditory epithelial cells.  We 
then compared the apoptotic effects of these compounds to those of cisplatin, which is a 
bifunctional platinum compound.  Our hypothesis was that the four monofunctional 
platinum compounds would cause reduced inner ear apoptosis compared to cisplatin. 
Zebrafish were injected with either vehicle solution, cisplatin or with one of the 
monofunctional compounds.  Later, at 24-hour and 48-hour time points, the zebrafish 
were euthanized, and two of their auditory inner ear endorgans, the utricle and saccule, 
were dissected out.  A terminal deoxynucleotidyl transferase (TdT)-mediated dUTP 
nick-end labeling (TUNEL) assay was then used to label apoptotic cells, and the inner 
ear organs were viewed under a microscope.  The number of apoptotic cells on each 
sample was quantified and the data were analyzed for significant differences between 
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treatments.  We found that with the exception of pyriplatin in the saccules, and with the 
exception of pyriplatin, Pt(N,N-diethyldiethylenetriamine)Cl, and phenanthriplatin in the 
utricles, the monofunctional compounds and cisplatin did not induce apoptosis in the 
inner ear of zebrafish at either time point.  Based on these results we conclude that the 
monofunctional platinum compounds largely do not induce zebrafish inner ear apoptosis 






As 7.6 million people die from cancer each year worldwide, developing novel 
chemotherapy drugs is of significant research interest (Johnstone et al. 2014).  Platinum-
based chemotherapy drugs are highly effective against some cancers, e.g., testicular 
cancer (Feldman et al. 2008), but are ineffective against most cancers and can produce 
serious side-effects including neurotoxicity, hearing damage (ototoxicity), and kidney 
damage (nephrotoxicity; Cepeda et al. 2007).  The FDA-approved platinum compound 
cisplatin, has two chloride leaving ligands that become aquated upon entry into cells, 
allowing them to bind both DNA strands, making cisplatin a bifunctional platinum 
compound (Knox et al. 1986, Jamieson & Lippard 1999, Raymond et al. 2000).  
Bifunctional binding typically causes DNA to bend, followed by the activation of 
apoptotic pathways, and cancer cell death (Jamieson & Lippard 1999, Cepeda et al. 
2007, Hellberg et al. 2009, Wang et al. 2010, Alian et al. 2012, Brock et al. 2012, Nitz et 
al. 2013).  However, platinum(II) compounds with only one chloride leaving ligand are 
monofunctional as they bind to only one strand of DNA and do not cause it to bend.  
Yet, they can still block RNA transcription in cancer cells and reduce their viability 
(Park et al. 2012).  Because monofunctional compounds can cause cancer cell death 
potentially through a different mechanism than bifunctional compounds, they may 
produce reduced side-effects, including decreased ototoxicity.  
Cisplatin auditory cell uptake and the mechanisms that cause ototoxicity have 
been studied in mammalian and zebrafish (Danio rerio) models.  Mammalian studies 
show that cisplatin uptake in auditory hair cells is membrane transporter-dependent 
  
2 
(Ciarimboli et al. 2010, More et al. 2010, Ding et al. 2011, Ciarimboli, 2012).  These 
studies implicate specific hair cell plasma membrane transporters, e.g., CTR1 and 
OCT2.  However, the mechanism of cisplatin uptake in zebrafish auditory cells may be 
different than their mammalian counterparts as zebrafish lateral line hair cells require 
mechanotransduction for cisplatin uptake and do not express the membrane transporters 
found in mammalian hair cells (Thomas et al. 2013).  At this time, cisplatin uptake in 
zebrafish inner-ear hair cells has not been characterized.   
Studies in both mammalian and zebrafish models have implicated a number of 
pathways in cisplatin-mediated ototoxicity.  In mammals, both DNA dependent and 
independent pathways of cisplatin ototoxicity have been identified (Karasawa and 
Steyger 2015).  Cisplatin can damage DNA and induce cytotoxicity in cochlear hair cells 
(Rybak et al. 2007; Slattery et al. 2014).  However, reactive oxygen species (ROS) 
mechanisms independent of DNA damage can cause ototoxicity by ROS targeting of 
cytoplasmic molecules, e.g., glutathione (Fuertes et al 2003; Karasawa 2015).  Less is 
known about ototoxicity mechanisms in zebrafish, but studies have shown that 
ototoxicity in zebrafish signal through proteins, e.g., Bax, Bcl2, p38, p53 and 
cytochrome c, that are implicated in rodent apoptosis (Coffin et al. 2013a,b; Shin et al. 
2013).  
 This study used zebrafish inner ear auditory system tissue to investigate the 
apoptotic effects of four platinum-based compounds with only one leaving ligand.  
These compounds are the triamine-ligated platinum(II) complexes: 
Pt(diethylenetriamine)Cl, [Pt(dien)Cl]+, and Pt(N,N-diethyldiethylenetriamine)Cl, 
[Pt(Et2dien)Cl]
+, and the monofunctional heterocyclic-ligated platinum(II) complexes: 
  
3 
pyriplatin and phenanthriplatin.  These compounds can form monofunctional adducts 
with DNA nucleotides that could potentially block RNA transcription and induce 
apoptosis in cancer cells (Park et al. 2012, Monroe et al. 2018).  As transcription is 
increased in cancer cells relative to non-cancerous auditory cells, these compounds 
might be able to block transcription in cancer cells and cause their apoptotic destruction 
without causing apoptosis and ototoxicity in auditory hair cells.   
The zebrafish inner-ear model has been successfully used to identify and 
quantify drug-induced apoptosis in auditory sensory tissues using the terminal 
deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) assay 
(Smith et al. 2006; Sun et al. 2011).  Here, the inner-ear model and TUNEL staining was 
used to determine whether platinum compounds with one leaving ligand caused 
apoptosis in two zebrafish inner ear auditory sensory structures, the saccule and the 
utricle.     
These experiments investigated the hypothesis: Monofunctional platinum(II) 
amine complexes that do not distort DNA will cause reduced apoptosis in zebrafish 
inner-ear tissue compared to the DNA-distorting bifunctional complex, cisplatin. The 
information obtained from this work should be valuable in the design of new anticancer 
drugs and the analysis of their ototoxicity and cancer cell cytotoxicity characteristics and 
mechanisms.  Thus, this research could potentially identify novel platinum compounds 






Materials and Methods 
Zebrafish were housed in the animal facility at Western Kentucky University and 
cared for per the protocol described by (Westerfield 1994). This protocol has been 
approved by the Institutional Animal Care and Use Committee of Western Kentucky 
University.  A total of 140 zebrafish (from which 68 saccule and 45 utricle samples were 
recovered) were randomly selected from a population containing both males and females 
and were injected with one of the four monofunctional compounds, cisplatin, or 0.9% 
NaCl vehicle control.  The fish ranged in mass from 0.1 g to 0.9 g at the time of 
injection. The mean ( S.E.) mass of fish used in the 24 hour treatments was 0.40 g ( 
0.03), and the average mass of fish used in the 48 hour treatments was 0.36 g ( 0.01). 
0.015 milligrams of platinum compound or vehicle volume equivalent per gram of body 
mass was injected into each fish.  The volumes injected ranged from 750 nL to 6750 nL.  
Injections were done using a microinjector (World Precision Instruments, Micro 4, 
Catalog #: SYS-MICRO4) and according to a protocol adapted from (Kinkel et al. 
2010).  Then, the fish were returned to the holding tank.  After either 24 or 48 hours, the 
fish were euthanized by exposing them to a lethal dose of MS-222, a common anesthetic 
used in aquatic research laboratories.  Surgical scissors were used to remove the fish 
heads and then the heads were placed in a vial containing 4% paraformaldehyde at 4o C. 
After 24 hours, but not more than 6 days later, the heads were removed from the vial and 
washed in phosphate buffer (PB) three separate times, 15 minutes each time, for a total 
wash time of 45 minutes. After washing, the fish were dissected and the utricles and 
saccules removed using microsurgical tools and a Leica dissecting microscope.  A 
TUNEL assay was then performed on the tissue samples (Sun et al. 2011), followed by a 
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mounting procedure (Olivari et al. 2008), during which the samples were placed in a 
small pool of Prolong Gold Antifade reagent containing the nuclear stain, 4’,6-
diamidino-2-phenylindole (DAPI), and mounted on a microscope slide.  The samples 
were secured by carefully depositing a microscope coverslip on top of them and fixing 
the coverslip in place using nail polish.  The slide containing the mounted samples was 
then quickly placed in a dark box and put in a refrigerator at 4o C until quantification.   
A Zeiss Axioplan 2 epifluorescence microscope was used in conjunction with a 
AxioCam MRm camera to observe the samples and to photograph them at 10X, 20X, 
and 100X magnification.  Each image was taken using the FITC and DAPI camera 
filters.  Zeiss Axioplan software was then used to count the number of TUNEL-labeled 
apoptotic cells present in each sample (Zeiss Axioplan, Axiovision Release 4.8.2 SP3 
08-2013).  The specific pathway for quantifying cells was: measure/interactive 
measurement/start measurement/.  Then, the “Event Feature” was used to mark and 
count apoptotic cells.  GraphPad Prism v6 (La Jolla, CA) was used for all statistical 
analysis.  To determine whether there were significant differences in the amount of 
apoptosis generated by the platinum compounds compared to vehicle, and to compare 










This project used TUNEL staining to quantify the apoptotic effects of several 
monofunctional platinum complexes and the bifunctional compound, cisplatin, in 
zebrafish auditory tissue.  Our analysis of saccular apoptosis at 24 hours revealed that 
only one of the compounds, pyriplatin, caused a significant effect when compared with 
vehicle (p < 0.05; Figure 2).  No significant apoptosis was found in saccules treated with 
any of these compounds at 48 hours (Figure 3).  When we quantified saccular apoptosis, 
we found the following mean ± S.E. values in apoptotic saccular samples treated for 24 
hours: [Pt(dien)Cl]+ (79.0  9.3), pyriplatin (65.8  3.6), cisplatin (57.3  6.2), 
[Pt(Et2dien)Cl]
+ (56.3  7.4), phenanthriplatin (53.2  12.5), and vehicle (29.7  3.3).  
The mean values obtained for samples treated for 48 hours were: pyriplatin (82.8  8.0), 
vehicle (58.3  8.0), [Pt(Et2dien)Cl]
+ (53.4  5.0), [Pt(dien)Cl]+ (47.0  3.7), 
phenanthriplatin (31.8  5.8), and cisplatin (9.7  1.7).  No evident treatment category 
trend is identifiable in saccules when the mean values are compared across the 24 and 48 
hour time points.     
Our analysis of utricular apoptosis was largely similar to our findings with 
saccules.  [Pt(Et2dien)Cl]
+ caused a significant increase in apoptosis compared to control 
at the 24 hour time point (p < 0.01; Figure 4).  Both pyriplatin and phenanthriplatin 
caused significantly more apoptosis at 48 hours than control (p < 0.01; Figure 5).  
However, as there was only one data point for the [Pt(dien)Cl]+ treatment at 24 hours, 
we were not able to comparatively analyze this value.  When we quantified utricular 
apoptosis, we found the following mean values in samples treated for 24 hours: 
[Pt(Et2dien)Cl]
+ (106.2  4.1), phenanthriplatin (100.5  12.4), pyriplatin (76.8  7.9), 
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vehicle (57.2  4.0), [Pt(dien)Cl]+ (51.0  0.0) and cisplatin (39.0  9.9).  The mean 
values obtained for utricles treated for 48 hours were: [Pt(Et2dien)Cl]
+  (257.5  103.6), 
pyriplatin (118.7  15.6), [Pt(dien)Cl]+ (117.0  22.6), phenanthriplatin (94.5  9.5), 
cisplatin (11.3  3.2), and vehicle (3.2  0.6).  As with saccules, no evident treatment 
category trend is identifiable in utricles when their mean values are compared across the 
24 and 48 hour time points.      
We also compared the 24 and 48 hour data sets to identify potential temporal 
effects from treatment with these platinum compounds.  Our results showed that in 
saccules, only cisplatin treatment produced a significantly lower number of apoptotic 
cells at 48 hours when compared to the 24 hour time point (p < 0.01; Figure 6).  
However, the saccular sensory epithelia for cisplatin samples treated at 48 hours 
exhibited signs of damage, which may account for the lower apoptotic cell counts at that 
time point.  When we compared utricular samples at 24 and 48 hours, we found that 
vehicle samples at 48 hours were significantly lower than the samples treated with 
vehicle at 24 hours (p < 0.01; Figure 7).  However, as with the 48 hour saccular cisplatin 
samples, the utricular vehicle samples taken at this time point also exhibited signs of 
damage, which again could explain the lower apoptotic cell count at 48 hours. 
8 
Figure 1. TUNEL-labeled saccule (A) and utricle (B) 24 hours post-vehicle injection. 




Figure 2: Pyriplatin treatment increases apoptosis in zebrafish saccules 24 hours post- 
injection.  Data indicate the mean ( S.E.) number of apoptotic cells counted in saccular 
tissue treated with vehicle, cisplatin, and four monofunctional platinum compounds.  
Pyri = pyriplatin, Phen = phenanthriplatin, Pt(dien) = Pt(diethylenetriamine)Cl, 




Figure 3: Platinum compound treatment does not affect apoptosis in zebrafish saccules 
48 hours post-injection.  Data indicate the mean ( S.E.) number of apoptotic cells 
counted in saccular tissue treated with vehicle, cisplatin and four monofunctional 
platinum compounds.  Pyri = pyriplatin, Phen = phenanthriplatin, Pt(dien) = 
Pt(diethylenetriamine)Cl, Pt(Et2dien) = Pt(N,N-diethyldiethylenetriamine)Cl.  N = 5-7; 





Figure 4: Pt(Et2dien)Cl treatment increases apoptosis in zebrafish utricles 24 hours post-
injection.  Data indicate the mean ( S.E.) number of apoptotic cells counted in utricular 
tissue treated with vehicle, cisplatin and four monofunctional platinum compounds.  Pyri 
= pyriplatin, Phen = phenanthriplatin, Pt(dien) = Pt(diethylenetriamine)Cl, Pt(Et2dien) = 




Figure 5: Both pyriplatin and phenanthriplatin treatment increases apoptosis in zebrafish 
utricles after 48 hours exposure.  Data indicate the mean ( S.E.) number of apoptotic 
cells counted in utricular tissue treated with vehicle, cisplatin and four monofunctional 
platinum compounds.  Pyri = pyriplatin, Phen = phenanthriplatin, Pt(dien) = 
Pt(diethylenetriamine)Cl, Pt(Et2dien) = Pt(N,N-diethyldiethylenetriamine)Cl.  N = 2-6. 




Figure 6: Comparison of 24- and 48-hour saccular apoptosis data for each treatment.  
Ve-24 = Vehicle at 24 hours, Ve-48 = Vehicle at 48 hours, Ci-24 = Cisplatin at 24 
hours, Ci-48 = Cisplatin at 48 hours, Py-24 = Pyriplatin at 24 hours, Py-48 = Pyriplatin 
at 48 hours, Ph-24 = Phenanthriplatin at 24 hours, Ph-48 = Phenanthriplatin at 48 hours, 
Di-24 =  Pt(diethylenetriamine)Cl at 24 hours, Di-48 = Pt(diethylenetriamine)Cl at 48 
hours, Et-24 =  Pt(N,N-diethyldiethylenetriamine)Cl at 24 hours, Et-48 = Pt(N,N-




Figure 7: Comparison of 24- and 48-hour utricular apoptosis data for each treatment. 
Ve-24 = Vehicle at 24 hours, Ve-48 = Vehicle at 48 hours, Ci-24 = Cisplatin at 24 
hours, Ci-48 = Cisplatin at 48 hours, Py-24 = Pyriplatin at 24 hours, Py-48 = Pyriplatin 
at 48 hours, Ph-24 = Phenanthriplatin at 24 hours, Ph-48 = Phenanthriplatin at 48 hours, 
Di-24 =  Pt(diethylenetriamine)Cl at 24 hours, Di-48 = Pt(diethylenetriamine)Cl at 48 
hours, Et-24 =  Pt(N,N-diethyldiethylenetriamine)Cl at 24 hours, Et-48 = Pt(N,N-









Platinum compounds that bind to DNA differently than cisplatin could cause 
reduced apoptosis in auditory tissue.  Cisplatin has two leaving ligands that become 
aquated after entering cells, which enables the ligands to bind to both DNA strands 
(Jamieson et al. 1999; Knox et al. 1986; Cepeda et al. 2007).  Binding to both strands 
causes DNA to bend and the subsequent recruitment of apoptotic proteins that activate 
cell death pathways and the termination of RNA transcription (Jamieson et al. 1999; 
Knox et al. 1986; Cepeda et al. 2007).  Unfortunately, cisplatin typically targets non-
cancerous cells, including auditory hair cells, where it can cause cell death by activating 
apoptotic mechanisms and releasing reactive oxygen species (Hellberg et al. 2009; 
Karasawa and Steyger 2015).  Recently, monofunctional platinum compounds with only 
one leaving ligand have been proposed as chemotherapy drug candidates (Lovejoy and 
Lippard 2009; Park et al. 2012; Johnston et al. 2014).  As these compounds have only 
one leaving ligand, they only bind one DNA strand and do not cause the DNA to bend 
(Park et al. 2012; Johnston et al. 2014).  Instead, these monofunctional compounds are 
thought to cause apoptosis by blocking RNA polymerase II and preventing transcription 
(Park et al. 2012; Johnston et al. 2014).  As monofunctional compounds do not cause 
DNA distortion like cisplatin, this suggests that they could modulate cancer cell 
cytotoxicity differently than their bifunctional counterparts.  Specifically, 
monofunctional compounds could impair transcription more strongly in cancer cells, 
where mRNA production is upregulated, and have more limited impact on non-cancer 
cells, e.g., auditory hair cells, where fewer genes would be undergoing transcription.  
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Therefore, monofunctional compounds might produce fewer side-effects in auditory 
tissue than in cells treated with cisplatin.  
 Monofunctional platinum compounds that work by blocking transcription would 
be expected to produce less apoptosis in auditory tissue than cisplatin.  However, our 
results suggest that the amount of apoptosis caused by these monofunctional compounds 
is not different than that of cisplatin.  In saccules, cisplatin treatment at 24 hours 
produces a very similar mean number of apoptotic cells as the monofunctional 
compounds (Figure 2), and, surprisingly, at 48 hours, produces the lowest mean number 
of apoptotic cells of any treatment category (Figure 3).  The low level of apoptosis for 
cisplatin observed in saccular samples at 48 hours may be due to sensory epithelial 
damage sustained during the dissecting process.  Our utricle data at 24 hours shows that 
cisplatin treatment caused the lowest mean number of apoptotic cells and that 
[Pt(Et2dien)Cl]
+ caused significantly more apoptosis than control (Figure 4).  Similarly, 
our utricle data at 48 hours shows that cisplatin treatment again caused the lowest mean 
number of apoptotic cells and that both pyriplatin and phenanthriplatin caused 
significantly more apoptosis than control (Figure 5).  These results could be interpreted 
to mean that both the monofunctional compounds and cisplatin cause auditory tissue 
apoptosis primarily by blocking mRNA transcription, and that cisplatin-modulated 
apoptosis from DNA distortion is negligible.  Alternatively, it could be that the apoptotic 
mechanisms activated by cisplatin and the monofunctional compounds signal initially 
through distinct molecular components, but that subsequently these different signals 
become integrated into a common downstream pathway.  This interpretation is 
suggested by research showing that zebrafish and mammalian ototoxins signal through 
  
17 
common molecular effectors, e.g., Bax, Bcl2, p38, p53 and cytochrome c (Coffin et al. 
2013a,b; Shin et al. 2013).  Therefore, cisplatin and monofunctional apoptotic signaling 
could proceed initially mainly through a common pathway or be integrated later in 
another pathway to produce similar apoptotic effects.     
Cisplatin and the four monofunctional compounds can affect auditory tissue and 
function in distinct ways.  Electron microscopy studies have shown that cisplatin can 
cause extensive damage to zebrafish inner ear tissue (Giari et al. 2012).  Further, a recent 
study of these four monofunctional compounds and cisplatin found that at 48 hours all of 
the monofunctional compounds, with the exception of pyriplatin, caused significantly 
higher temporary threshold shifts than cisplatin (Monroe et al. 2018).  This study also 
found that cisplatin reduced saccular hair cell density to a much greater extent than the 
monofunctional compounds, but that none of the compounds reduced hair cell density in 
the utricle (Monroe et al. 2018).  As the saccule is the primary zebrafish auditory 
endorgan (Popper et al. 2003), our data suggests that the number of apoptotic cells are 
not well correlated with hearing threshold shifts associated with these compounds.  Our 
utricle data is generally more in conformity with the results reported in Monroe et al. 
(2018), although pyriplatin, phenanthriplatin, and [Pt(Et2dien)Cl]
+ were found to 
increase the number of apoptotic cells compared to control at one of the two time points 
(Figures 4-5).  However, our control data set at 48 hours is difficult to interpret due to 
the presence of damage to the sensory epithelia of some of the samples.  Taken together, 
our saccular and utricular data indicate that the mean number of apoptotic cells and hair 
cell density are not particularly correlated. 
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The apoptotic action of cisplatin and the monofunctional compounds could 
depend upon distinct time courses.  Our results showed that apart from cisplatin 
treatment in the saccule and vehicle treatment in the utricle, where damage in the 48 
hour sensory epithelial samples was present, all treatments caused similar levels of inner 
ear apoptosis at the 24- and 48-hour time points in both saccules and utricles (Figure 6-
7).  It is possible that peak apoptosis for either cisplatin or the monofunctional 
compounds occurs at a time point either before or after the 24 and 48 hour time points 
examined in this study.  Cisplatin can cause hearing deficits in zebrafish after 48 hours 
exposure but not after only 24 hours exposure (Monroe et al. 2018).  Similarly, goldfish 
(Carassius auratus) exposed to white noise for 48 hours experienced temporal shifts in 
apoptosis in the inner ear but these shifts differed by auditory endorgan.  In the saccule, 
apoptosis was greatest immediately after the acoustical trauma, but in the utricle, 
apoptosis peaked 24 hours later (Smith et al. 2006).  Since the saccule is thought to be 
the primary endorgan for hearing and the utricle the primary vestibular endorgan (Kwak 
et al. 2006), an acoustical stimulus might promote apoptosis sooner in the saccule than 
in the utricle.  These studies suggest that drug-induced apoptosis could also follow 
different time courses in either the saccule or utricle.  Our results indicate that cisplatin 
and the monofunctional compounds largely do not have this effect in either endorgan.  
However, it is possible that at other time points than the ones studied here, these 
compounds could begin to exhibit significantly lower or higher numbers of apoptotic 
cells.   
In these experiments, we analyzed significance by quantifying and comparing 
the number of apoptotic cells observed in individual saccules and utricles.  If these 
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values were instead reconsidered in terms of a percent of the total number of cells 
present in the sensory epithelia, it could be that apoptosis is an insignificant 
phenomenon at either 24 or 48 hours.  This interpretation could mean that the auditory 
threshold shifts caused by the monofunctional compounds in Monroe et al. (2018) might 
be from a transient physiological effect and that recovery of auditory function could 
occur at a later time point.  Additional study is required to evaluate whether cisplatin or 
the monofunctional compounds cause reversible or irreversible physiological damage to 
the saccular and utricular cells and the time point range in which significant apoptosis 
occurs.    
In conclusion, only one of the compounds, pyriplatin, caused significant 
apoptosis in the saccules of zebrafish at either time point, and [Pt(Et2dien)Cl]
+, 
pyriplatin, and phenanthriplatin caused significant apoptosis in the utricles at one of the 
two points.  However, this conclusion is somewhat tentative as some of the treatments 
require additional data from higher quality samples which would allow us to perform a 
more powerful analysis.  This information is particularly needed for the cisplatin 48-
hour saccule and vehicle 48-hour utricle data sets.  Evidently, additional investigation of 
how cisplatin and these monofunctional compounds function temporally, 
mechanistically and physiologically is needed.  Acquiring this information should allow 
a more precise determination of the relationships between apoptosis, hair cell density 
and auditory function in the zebrafish inner ear model during platinum(II) compound 
treatment.  These future studies should allow us to establish whether these 
monofunctional compounds can act as effective chemotherapy agents with reduced 
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